Health
Rutgers leading a clinical trial assessing combination treatment for coronavirus – News-Medical.Net
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with…
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic. The trial is being conducted with Synavir Corporation, a global health company that works with academia, industry and government to develop combination treatments for new viral infections.
The trial — called Triple Combination Antiviral Coronavirus Therapy (TriACT) — seeks to determine…
-
Noosa News17 hours agoProtest calls for shark net removal
-
General16 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News19 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Noosa News10 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat